AVEANNA HEALTHCARE HOLDINGS (NASDAQ:AVAH) Shows High-Growth Momentum and Strong Technical Uptrend

Last update: Dec 2, 2025

A basic rule of momentum investing is to seek stocks showing both firm price trends and quickening business foundations. The method used here joins two effective screening systems to find these candidates. First, the Mark Minervini Trend Template is used to confirm a stock is in a technically good, clear uptrend, removing poor or consolidating patterns. Second, a High Growth Momentum (HGM) rating evaluates the company's financial speed, searching for major and frequently quickening growth in earnings, sales, and cash flow. This two-part method aims to locate firms where better operational results are being acknowledged and valued by the market with continued price gains.

Aveanna Healthcare Holdings (NASDAQ:AVAH) appears from this joined screen, offering a case study in matching technical condition with fundamental momentum.

Technical Match with the Minervini Trend Template

The Minervini Trend Template gives a precise technical list made to find stocks in a verified Stage 2 advance. AVAH now meets the main rules of this template, which is vital for the strategy as it concentrates capital on stocks where the main trend is clearly upward, raising the chance of a good trade.

Price vs. Moving Averages: The stock trades above its rising 50-day ($9.03), 150-day ($6.81), and 200-day ($6.29) simple moving averages. This ordered position confirms the short, intermediate, and long-term trends are all positive.
Moving Average Order: The 50-day SMA is above both the 150-day and 200-day SMAs, while the 150-day SMA is above the 200-day SMA. This successive positive order signals quickening momentum across periods.
Nearness to Highs: With a present price near $9.28, AVAH is about 153% above its 52-week low of $3.67 and within 10% of its 52-week high of $10.32. Minervini’s thinking stresses that strength leads to more strength, and leaders often reach new highs.
Strong Relative Strength: A ChartMill Relative Strength (CRS) score of 92.72 shows AVAH has done better than over 92% of the market. High relative strength is a key part of the strategy, finding sector leaders that draw institutional money.

Fundamental Reasons for High Growth Momentum

While the chart shows the result, the High Growth Momentum rating aims to find the source. For AVAH, the basic financial numbers show a firm in a strong earnings turn, a main catalyst the Minervini strategy looks for.

Very High Earnings Growth: The most notable numbers are in earnings per share (EPS). Year-over-year EPS growth for the trailing twelve months is at a notable 2,500%. Recent quarterly comparisons show growth rates of 650%, 1,700%, and 433% over the past three quarters, marking a sharp and continued shift to profitability.
Positive Estimate Changes: Analyst view is getting better, with the average EPS estimate for the next fiscal year moved up by 10.85% over the last three months. Upward changes often come before more price momentum as the market adapts to better outlooks.
Growing Profit Margins: The company’s profit margin has shown big step-by-step improvement, growing from 0.93% two quarters ago to 4.58% in the latest quarter. Growing margins indicate pricing ability and operational efficiency improvements, which are prized by growth investors.
Steady Delivery: AVAH has exceeded consensus EPS estimates in each of the last four quarters, with an average exceedance of over 2,400%. This steady history of beating forecasts builds trust and can lead to higher valuations.

Technical Condition and Setup Evaluation

Beyond the basic Trend Template, a wider technical study gives background for possible entry and risk management. According to ChartMill’s own analysis, AVAH is given a high Technical Rating of 9 out of 10, mirroring its sound trend condition and market-leading performance. The long-term and short-term trends are both rated as positive, and the stock performs better than 84% of its peers in the Health Care Providers & Services industry.

The analysis states that while the technical base is very good, the immediate setup quality is rated a 6. This indicates the stock has been rising forcefully and might gain from a time of consolidation or a decline to give a more favorable, lower-risk entry chance. The report finds key support areas between $8.44-$8.65 and near $8.29, which could act as sensible zones for the stock to find buyers on any drop.

For a full look at the support levels, trend signals, and a sample trade setup, you can see the complete ChartMill Technical Analysis Report for AVAH.

Locating Comparable Chances

The joining of strict trend-following and growth momentum screening can methodically find possible leaders like AVAH. This particular analysis was produced by a set screen that filters for stocks fitting the Minervini Trend Template while also having a firm High Growth Momentum rating.

If you want to find other stocks that now match this "High Growth Momentum + Trend Template" profile, you can view the live screen results here: High Growth Momentum & Trend Template Screen.

Summary

Aveanna Healthcare Holdings shows the kind of chance looked for by a joined trend and growth momentum strategy. Technically, the stock is in a clear leading spot, trading near highs with strong relative strength and all major moving averages in a positive order, signs of the Minervini Trend Template. Fundamentally, it is backed by a changing earnings rebound, growing margins, and positive analyst changes, which support its high growth momentum rating. While the forceful recent rise indicates waiting for a better entry setup may be wise, the coming together of these points makes AVAH a stock worth more review for investors focused on high-growth momentum.

Disclaimer: This article is for informational and educational purposes only. It is not a recommendation to buy or sell any security. The analysis is based on data provided and certain screening methodologies. Always conduct your own due diligence, consider your risk tolerance, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.